Systematic review and meta-analysis of the diagnostic value of radionuclide imaging for thyroid nodules

There are many studies on diagnostic imaging of thyroid nodules, among which radionuclide scanning imaging has been proven to be very effective in identifying malignant lesions of thyroid nodules and is now widely used in the clinical detection of thyroid nodules.

Studies on radionuclide imaging in the diagnosis of thyroid nodules were searched in multiple Chinese and English databases, including PubMed, Web of Science, Embase, and The Cochrane Library as of July 1, 2021. The search terms included "clinical experiment", "thyroid nodule", "radionuclide imaging", "thyroid mass", "thyroid masses", "postoperative pathology", and "histopathology". The basic information and evaluation indicators in the literature were screened and extracted. Subsequently, meta-analysis was performed using RevMan 5.3 and Stata 13 software provided by the Cochrane system. In addition, forest plots and summary receiver operating characteristic (SROC) curves were drawn.

Seven randomized controlled trails (RCTs) were included in this study. The radionuclide imaging of thyroid nodule showed the area under SROC curve of 0.38. The combined diagnostic sensitivity and specificity were 0.66 [95% confidence interval (CI): 0.46, 0.89] and 0.36 (95% CI: 0.21, 0.59), respectively. The combined positive likelihood ratio (LR) and negative LR were 0.66 (95% CI: 0.53, 0.87) and 0.67 (95% CI: 0.43, 0.95), respectively. In addition, the combined diagnostic odds ratio (OR) was 4.45 (95% CI: 0.25, 10.57).

In this study, meta-analysis was used to confirm the application value of radionuclide imaging in the diagnosis of thyroid nodules. In the future, the value of radionuclide imaging in the diagnosis of thyroid nodules should be compared with other imaging detection methods.